• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化酪氨酸-294、-404和-451在RET/PTC1诱导的甲状腺肿瘤形成中的作用。

The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.

作者信息

Buckwalter Tara L F, Venkateswaran Anjli, Lavender Marc, La Perle Krista M D, Cho Je-Yoel, Robinson Michael L, Jhiang Sissy M

机构信息

Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio, OH 43210, USA.

出版信息

Oncogene. 2002 Nov 21;21(53):8166-72. doi: 10.1038/sj.onc.1205938.

DOI:10.1038/sj.onc.1205938
PMID:12444552
Abstract

RET/PTC1 is a rearranged form of the RET proto-oncogene detected in human papillary thyroid carcinomas. We previously showed that thyroid-targeted expression of RET/PTC1 leads to thyroid tumor formation in Tg-PTC1 transgenic mice. Signal transduction pathways mediated by phosphotyrosine 294, 404, or 451 in RET/PTC1 have been shown to be critical for RET-induced transforming activity in vitro. To investigate the contribution of these signaling pathways in RET/PTC1-induced thyroid tumor formation in vivo, we generated and characterized transgenic mice expressing thyroid-targeted RET/PTC1 mutants carrying a site-directed mutation changing tyrosine (Y) to phenylalanine (F) at the residue 294, 404, or 451. In contrast to the 100% tumor formation rate in Tg-PTC1 transgenic mice, tumor formation rates were significantly decreased in Tg-PTC1-Y294F (6%), Tg-PTC1-Y404F (41%), and Tg-PTC1-Y451F (30%) transgenic mice. This indicates that signaling pathways mediated by pY294, pY404, and pY451 do play a role in RET/PTC1-induced tumor formation. However, as tumors are still able to form in some mice within these three mutant transgenic groups, it indicates that none of the signaling pathways mediated by pY294, pY404, or pY451, are solely essential for RET/PTC1-induced tumor formation.

摘要

RET/PTC1是在人类甲状腺乳头状癌中检测到的RET原癌基因的重排形式。我们之前表明,在Tg-PTC1转基因小鼠中,甲状腺靶向性表达RET/PTC1会导致甲状腺肿瘤形成。已证明RET/PTC1中由磷酸酪氨酸294、404或451介导的信号转导通路对于RET在体外诱导的转化活性至关重要。为了研究这些信号通路在RET/PTC1诱导的体内甲状腺肿瘤形成中的作用,我们构建并鉴定了表达甲状腺靶向性RET/PTC1突变体的转基因小鼠,这些突变体在第294、404或451位残基处携带将酪氨酸(Y)突变为苯丙氨酸(F)的定点突变。与Tg-PTC1转基因小鼠100%的肿瘤形成率相比,Tg-PTC1-Y294F(6%)、Tg-PTC1-Y404F(41%)和Tg-PTC1-Y451F(30%)转基因小鼠的肿瘤形成率显著降低。这表明由pY294、pY404和pY451介导的信号通路确实在RET/PTC1诱导的肿瘤形成中发挥作用。然而,由于在这三个突变转基因组中的一些小鼠中仍能形成肿瘤,这表明由pY294、pY404或pY451介导的信号通路中没有一个对于RET/PTC1诱导的肿瘤形成是唯一必需的。

相似文献

1
The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.磷酸化酪氨酸-294、-404和-451在RET/PTC1诱导的甲状腺肿瘤形成中的作用。
Oncogene. 2002 Nov 21;21(53):8166-72. doi: 10.1038/sj.onc.1205938.
2
Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.RET/PTC1致癌基因在甲状腺靶向转基因小鼠中诱导的早期细胞异常。
Oncogene. 1999 Jun 17;18(24):3659-65. doi: 10.1038/sj.onc.1202709.
3
Thyroid carcinomas in RET/PTC transgenic mice.RET/PTC转基因小鼠中的甲状腺癌
Recent Results Cancer Res. 1998;154:265-70. doi: 10.1007/978-3-642-46870-4_17.
4
H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.H4(D10S170),一种在甲状腺乳头状癌中常与RET基因重排的基因:功能特征
Oncogene. 2004 Jan 8;23(1):109-21. doi: 10.1038/sj.onc.1206981.
5
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.RET/PTC(在转化/甲状腺乳头状癌中重排)酪氨酸激酶使磷酸肌醇依赖性激酶1(PDK1)磷酸化并激活:一条独立于磷脂酰肌醇3激酶激活PDK1的替代途径。
Mol Endocrinol. 2003 Jul;17(7):1382-94. doi: 10.1210/me.2002-0402. Epub 2003 May 8.
6
Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.台湾华人散发性乳头状甲状腺癌中RET重排(RET/PTC1、RET/PTC2、RET/PTC3和ELKS-RET)的低发生率
Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326.
7
Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.乳头状甲状腺癌:来自2个家族的6例病例,伴有淋巴细胞性甲状腺炎,存在RET/PTC重排。
Br J Cancer. 2001 Dec 14;85(12):1831-7. doi: 10.1054/bjoc.2001.2187.
8
[Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].甲状腺乳头状癌相关基因PTC1对ATM细胞亚细胞定位及功能的影响
Ai Zheng. 2004 May;23(5):487-92.
9
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.携带RET/PTC1癌基因的转基因小鼠乳腺和皮肤腺肿瘤的发生
Oncogene. 1996 Nov 7;13(9):2021-6.
10
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.PC Cl 3甲状腺细胞中的RET/PTC1癌基因信号传导需要小GTP结合蛋白Rho。
Oncogene. 2001 Oct 25;20(48):6973-82. doi: 10.1038/sj.onc.1204886.

引用本文的文献

1
Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.探讨分化型甲状腺癌发病机制的小鼠模型:最新进展。
Int J Mol Sci. 2023 Jul 6;24(13):11138. doi: 10.3390/ijms241311138.
2
Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models.滤泡细胞源性甲状腺癌的临床前模型:从癌细胞系到小鼠模型的概述。
Endocrinol Metab (Seoul). 2022 Dec;37(6):830-838. doi: 10.3803/EnM.2022.1636. Epub 2022 Dec 26.
3
Mouse models of thyroid cancer: A 2015 update.甲状腺癌小鼠模型:2015年更新
Mol Cell Endocrinol. 2016 Feb 5;421:18-27. doi: 10.1016/j.mce.2015.06.029. Epub 2015 Jun 27.
4
Thyroid cancer: pathogenesis and targeted therapy.甲状腺癌:发病机制与靶向治疗。
Ther Adv Endocrinol Metab. 2011 Oct;2(5):173-95. doi: 10.1177/2042018811419889.
5
The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression.胰岛素抵抗 Grb14 衔接蛋白促进甲状腺癌复发信号转导和进展。
Oncogene. 2012 Sep 6;31(36):4012-21. doi: 10.1038/onc.2011.569. Epub 2011 Dec 12.
6
Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.曲古抑菌素 A 和鱼藤酮协同抑制携带 RET/PTC1 癌基因的癌细胞生长,涉及增强细胞死亡。
J Biosci. 2011 Sep;36(4):639-48. doi: 10.1007/s12038-011-9100-7.
7
Mouse models of endocrine tumours.内分泌肿瘤的小鼠模型。
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):451-60. doi: 10.1016/j.beem.2010.01.004.
8
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.RET/PTC-RAS-BRAF线性信号级联介导甲状腺癌细胞的运动性和促有丝分裂表型。
J Clin Invest. 2005 Apr;115(4):1068-81. doi: 10.1172/JCI22758. Epub 2005 Mar 10.